Search Results - "Allard, Jeffrey"

Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival by HAYES, Daniel F, CRISTOFANILLI, Massimo, BUDD, G. Thomas, ELLIS, Matthew J, STOPECK, Alison, MILLER, M. Craig, MATERA, Jeri, ALLARD, W. Jeffrey, DOYLE, Gerald V, TERSTAPPEN, Leon W. W. M

“…Purpose: We reported previously that ≥5 circulating tumor cells (CTC) in 7.5 mL blood at baseline and at first follow-up in 177 patients with metastatic breast…”
Get full text

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases by ALLARD, W. Jeffrey, MATERA, Jeri, MILLER, M. Craig, REPOLLET, Madeline, CONNELLY, Mark C, RAO, Chandra, TIBBE, Arjan G. J, UHR, Jonathan W, TERSTAPPEN, Leon W. M. M

“…Purpose: The purpose of this study was to determine the accuracy, precision, and linearity of the CellSearch system and evaluate the number of circulating…”
Get full text

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer by Cristofanilli, Massimo, Budd, G. Thomas, Ellis, Matthew J, Stopeck, Alison, Matera, Jeri, Miller, M. Craig, Reuben, James M, Doyle, Gerald V, Allard, W. Jeffrey, Terstappen, Leon W.M.M, Hayes, Daniel F

“…An automated device that separates, identifies, and enumerates epithelial cells in whole blood was used to measure levels of circulating tumor cells in women…”
Get full text

Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer by CRISTOFANILLI, Massimo, HAYES, Daniel F, FRITSCHE, Herbert A, HORTOBAGYI, Gabriel N, TERSTAPPEN, Leon W. M. M, BUDD, G. Thomas, ELLIS, Mathew J, STOPECK, Alison, REUBEN, James M, DOYLE, Gerald V, MATERA, Jeri, ALLARD, W. Jeffrey, MILLER, M. Craig

“…Metastatic breast cancer (MBC) is incurable; its treatment is palliative. We investigated whether the presence of circulating tumor cells (CTCs) predicts…”
Get full text

Soluble Mesothelin-Related Peptide Level Elevation in Mesothelioma Serum and Pleural Effusions by Pass, Harvey I., MD, Wali, Anil, PhD, Tang, Naimei, PhD, Ivanova, Alla, PhD, Ivanov, Sergey, PhD, Harbut, Michael, MD, Carbone, Michele, MD, PhD, Allard, Jeffrey, PhD

“…Background Soluble mesothelin-related peptide (SMRP) is a potential marker for malignant pleural mesothelioma (MPM), which may be useful for screening…”
Get full text

MESOMARK™ : A potential test for malignant pleural mesothelioma by BEYER, Heather L, GESCHWINDT, Ryan D, SARDESAI, Niranjan Y, GLOVER, Curtis L, TRAN, Ly, HELLSTROM, Ingegerd, HELLSTROM, Karl-Erik, MILLER, M. Craig, VERCH, Thorsten, ALLARD, W. Jeffrey, PASS, Harvey I

“…Soluble mesothelin-related peptides (SMRP)have been reported to be potential biomarkers for malignant pleural mesothelioma (MPM). We report analytical and…”
Get full text

TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells by Trotta, Rossana, Dal Col, Jessica, Yu, Jianhua, Ciarlariello, David, Thomas, Brittany, Zhang, Xiaoli, Allard, 2nd, Jeffrey, Wei, Min, Mao, Hsiaoyin, Byrd, John C, Perrotti, Danilo, Caligiuri, Michael A

“…TGF-beta can be a potent suppressor of lymphocyte effector cell functions and can mediate these effects via distinct molecular pathways. The role of TGF-beta…”
Get full text

The PP2A inhibitor SET regulates natural killer cell IFN-gamma production by Trotta, Rossana, Ciarlariello, David, Dal Col, Jessica, Allard, 2nd, Jeffrey, Neviani, Paolo, Santhanam, Ramasamy, Mao, Hsiaoyin, Becknell, Brian, Yu, Jianhua, Ferketich, Amy K, Thomas, Brittany, Modi, Aalok, Blaser, Bradley W, Perrotti, Danilo, Caligiuri, Michael A

“…Monokines (i.e., interleukin [IL]-12, -18, and -15) induce natural killer (NK) cells to produce interferon-gamma (IFN-gamma), which is a critical factor for…”
Get full text

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass by Moore, Richard G, McMeekin, D. Scott, Brown, Amy K, DiSilvestro, Paul, Miller, M. Craig, Allard, W. Jeffrey, Gajewski, Walter, Kurman, Robert, Bast, Robert C, Skates, Steven J

“…Abstract Introduction Patients diagnosed with epithelial ovarian cancer (EOC) have improved outcomes when cared for at centers experienced in the management of…”
Get full text

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass by Moore, Richard G, Brown, Amy K, Miller, M. Craig, Skates, Steven, Allard, W. Jeffrey, Verch, Thorsten, Steinhoff, Margaret, Messerlian, Geralyn, DiSilvestro, Paul, Granai, C.O, Bast, Robert C

“…Abstract Objectives. The CA125 tumor marker is used to help predict the presence of ovarian cancer in patients with an adnexal mass. Because elevated CA125…”
Get full text

Protein Profiling of Pleural Effusions to Identify Malignant Pleural Mesothelioma Using SELDI-TOF MS by Hegmans, Joost P.J.J., Veltman, Joris D., Fung, Eric T., Verch, Thorsten, Glover, Curtis, Zhang, Fujun, Allard, W. Jeffrey, T'Jampens, Davy, Hoogsteden, Henk C., Lambrecht, Bart N., Aerts, Joachim

“…Diagnosis of malignant pleural mesothelioma (MM) is limited. Novel proteomic technologies can be utilized to discover changes in expression of pleural proteins…”
Get full text

Relationship of Serum HER-2/neu and Serum CA 15-3 in Patients with Metastatic Breast Cancer by Ali, Suhail M, Leitzel, Kim, Chinchilli, Vernon M, Engle, Linda, Demers, Laurence, Harvey, Harold A, Carney, Walter, Allard, Jeffrey W, Lipton, Allan

“…Serum HER-2/neu antigen concentrations have been reported to correlate with increased tumor volume in patients with breast cancer. We measured serum CA 15-3, a…”
Get full text

CCR 20th Anniversary Commentary: Paving the Way for Circulating Tumor Cells by Allard, W Jeffrey, Terstappen, Leon W M M

“…Cancer cells can enter the bloodstream, form distant metastases, and ultimately lead to death. A study by Allard and colleagues, which was published in the…”
Get full text

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus by Moore, Richard G, Brown, Amy K, Miller, M. Craig, Badgwell, Donna, Lu, Zhen, Allard, W. Jeffrey, Granai, C.O, Bast, Robert C, Lu, Karen

“…Abstract Objective Tumor markers with increased sensitivity and specificity for endometrial cancer are needed to help monitor response to therapy and to detect…”
Get full text

Automated Assay for HER-2/neu in Serum by Payne, Robert C, Allard, Jeffrey W, Anderson-Mauser, Linda, Humphreys, John D, Tenney, Donald Y, Morris, David L

“…The extracellular domain of the HER-2/neu oncogene product is increased in sera of some patients with epithelial cancers. Our aim was to develop an automated…”
Get full text

Circulating tumor cells predict survival in patients with metastatic prostate cancer by Moreno, Jose G., Miller, M. Craig, Gross, Steve, Allard, W. Jeffrey, Gomella, Leonard G., Terstappen, Leon W.M.M.

“…To determine whether circulating tumor cells (CTCs) predict for survival in patients with metastatic prostate cancer (PCa) and to compare its prognostic…”
Get full text

Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation by Trotta, Rossana, Parihar, Robin, Yu, Jianhua, Becknell, Brian, Allard, Jeffrey, Wen, Jing, Ding, Wei, Mao, Hsiaoyin, Tridandapani, Susheela, Carson, William E., Caligiuri, Michael A.

“…Monocyte cytokines (ie, monokines) induce natural killer (NK) cells to produce interferon-γ (IFN-γ), which is critical for monocyte clearance of infectious…”
Get full text

Isolation and Characterization of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer by Cohen, Steven J., Alpaugh, R. Katherine, Gross, Steve, O'Hara, Shawn M., Smirnov, Denis A., Terstappen, Leon W.M.M., Allard, W. Jeffrey, Bilbee, Maryann, Cheng, Jonathan D., Hoffman, John P., Lewis, Nancy L., Pellegrino, Ann, Rogatko, André, Sigurdson, Elin, Wang, Hao, Watson, James C., Weiner, Louis M., Meropol, Neal J.

“…Development of targeted therapeutic agents in colorectal cancer (CRC) is impeded by the lack of a noninvasive surrogate of drug effect. This pilot study…”
Get full text

Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin by Dai, J, Allard, W J, Davis, G, Yeung, K K

“…We evaluated 56 monoclonal antibodies (MAbs), submitted to the ISOBM TD-4 Workshop, for changes in binding following desialylation of the MUC1 molecule and for…”
Get more information

Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer by Price, C P, Allard, J, Davies, G, Dawnay, A, Duffy, M J, France, M, Mandarino, G, Ward, A M, Patel, B, Sibley, P, Sturgeon, C

Get more information